TABLE 5

Incidence of FFP or Progressive Disease Based on PSMA PET Findings in Men Treated with sRT

PSMA PET resultFFP at 3 yProgressive diseaseOverall
Negative47 (82.5%)10 (17.5%)57/186 (31%)
Fossa-positive34 (79%)9 (21%)43/186 (23%)
Pelvic LN–positive33 (55%)26 (45%)59/186 (32%)
Distant LN–positive2 (25%)6 (75%)8/186 (4%)
Bone or viscera4 (21%)15 (79%)19/186 (10%)
Total120 (64.5%)66 (35.4%)186 (100%)